The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| HYPMY | +46.73% | +7.37% | +1.43% | -54% |
| S&P | +14.49% | +91.09% | +13.83% | +521% |
Hypera SA is a pharmaceutical company, which engages in the manufacture and distribution of medical and cosmetics products. Its products include foods and sweeteners; over-the-counter medication; prescribed medication; and dermocosmetics. The company was founded on December 1, 2001 and is headquartered in Sao Paulo, Brazil.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $408.77M | 18.3% |
| Gross Profit | $240.89M | 21.2% |
| Gross Margin | 58.93% | 1.4% |
| Market Cap | $2.65B | -13.7% |
| Net Income | $83.30M | 24.8% |
| EBITDA | $137.55M | 47.7% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $349.97M | -40.6% |
| Accounts Receivable | $299.10M | -45.6% |
| Inventory | 399.8 | 12.6% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $1.42B | -8.5% |
| Short Term Debt | $333.11M | -10.6% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 2.80% | -2.9% |
| Return On Invested Capital | 8.95% | -0.9% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $102.55M | 20.8% |
| Operating Free Cash Flow | $123.47M | 18.6% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 7.26 | 14.01 | 23.79 | 18.13 | 80.14% |
| Price to Book | 0.86 | 1.09 | 1.49 | 1.20 | -15.06% |
| Price to Sales | 1.36 | 1.76 | 2.72 | 2.20 | 8.08% |
| Price to Tangible Book Value | 19.47 | 43.06 | -208.48 | 155.26 | 275.81% |
| Price to Free Cash Flow TTM | 75.98 | 45.90 | 589.67 | 119.94 | 587.13% |
| Enterprise Value to EBITDA | 141.70 | -154.75 | 37.10 | 29.94 | -36.75% |
| Free Cash Flow Yield | 1.3% | 2.2% | 0.2% | 0.8% | -85.45% |
| Return on Equity | 11.8% | 6.9% | 6.1% | 6.6% | -51.18% |
| Total Debt | $1.55B | $1.66B | $1.66B | $1.75B | -8.94% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
